DE602006010386D1 - Phagen-display mittels cotranslationaler translokation von fusionspolypeptiden - Google Patents

Phagen-display mittels cotranslationaler translokation von fusionspolypeptiden

Info

Publication number
DE602006010386D1
DE602006010386D1 DE602006010386T DE602006010386T DE602006010386D1 DE 602006010386 D1 DE602006010386 D1 DE 602006010386D1 DE 602006010386 T DE602006010386 T DE 602006010386T DE 602006010386 T DE602006010386 T DE 602006010386T DE 602006010386 D1 DE602006010386 D1 DE 602006010386D1
Authority
DE
Germany
Prior art keywords
display
phage
fusionspolypeptiden
cotranslationaler
translokation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006010386T
Other languages
English (en)
Inventor
Daniel Steiner
Patrik Forrer
Michael T Stumpp
Andreas Plueckthun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Zuerich
Original Assignee
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Zuerich filed Critical Universitaet Zuerich
Publication of DE602006010386D1 publication Critical patent/DE602006010386D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
DE602006010386T 2005-07-08 2006-06-30 Phagen-display mittels cotranslationaler translokation von fusionspolypeptiden Active DE602006010386D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05106236 2005-07-08
PCT/EP2006/063729 WO2007006665A1 (en) 2005-07-08 2006-06-30 Phage display using cotranslational translocation of fusion polypeptides

Publications (1)

Publication Number Publication Date
DE602006010386D1 true DE602006010386D1 (en) 2009-12-24

Family

ID=35063135

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006010386T Active DE602006010386D1 (en) 2005-07-08 2006-06-30 Phagen-display mittels cotranslationaler translokation von fusionspolypeptiden

Country Status (21)

Country Link
US (2) US8846577B2 (de)
EP (1) EP1902131B1 (de)
JP (1) JP5042218B2 (de)
KR (1) KR101268939B1 (de)
CN (1) CN101213299B (de)
AT (1) ATE448305T1 (de)
AU (1) AU2006268780B2 (de)
BR (1) BRPI0613593A2 (de)
CA (1) CA2614512C (de)
DE (1) DE602006010386D1 (de)
DK (1) DK1902131T3 (de)
ES (1) ES2335136T3 (de)
HK (1) HK1122839A1 (de)
IL (1) IL188518A (de)
MX (1) MX2008000345A (de)
NO (1) NO20080665L (de)
NZ (1) NZ564695A (de)
PL (1) PL1902131T3 (de)
RU (1) RU2412249C2 (de)
WO (1) WO2007006665A1 (de)
ZA (1) ZA200710687B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004003144A2 (en) 2002-07-01 2004-01-08 Human Genome Sciences, Inc. Antibodies that specifically bind to reg iv
KR101491867B1 (ko) * 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
DK2358746T3 (da) 2008-11-03 2020-12-21 Molecular Partners Ag Bindingsproteiner til inhibering af vegf-a-receptorinteraktionen
GB0917647D0 (en) * 2009-10-08 2009-11-25 Glaxosmithkline Biolog Sa Expression system
NZ598901A (en) * 2009-11-05 2014-08-29 Genentech Inc Methods and composition for secretion of heterologous polypeptides
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
DK2643349T3 (da) 2010-11-26 2019-11-25 Molecular Partners Ag Designede repeat-proteiner, der binder til serumalbumin
EP3666289A1 (de) 2011-02-15 2020-06-17 ImmunoGen, Inc. Zytotoxische benzodiazepinderivate
TW201302779A (zh) * 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗
BR112013027766A2 (pt) 2011-04-29 2016-11-29 Janssen Biotech Inc proteinas de repetição de ligação de il4/il13 e usos
EA029797B1 (ru) 2011-06-21 2018-05-31 Иммуноджен, Инк. Новые производные майтанзиноида с пептидным линкером и их конъюгаты
KR20150023957A (ko) 2012-06-28 2015-03-05 몰리큘라 파트너스 아게 혈소판-유래 성장인자에 결합하는 설계된 안키린 반복 단백질
US9956341B2 (en) 2012-07-03 2018-05-01 Milestone Scientific, Inc. Drug infusion with pressure sensing and non-continuous flow for identification of and injection into fluid-filled anatomic spaces
WO2014031566A1 (en) 2012-08-22 2014-02-27 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
EP2738180A1 (de) 2012-11-30 2014-06-04 Molecular Partners AG Bindeproteine mit mindestens zwei Bindedomänen gegen HER2
EP3566750A3 (de) 2013-02-28 2020-04-08 ImmunoGen, Inc. Konjugate aus zellbindenden und zytotoxischen verbindungen
WO2014134486A2 (en) 2013-02-28 2014-09-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
WO2014194030A2 (en) 2013-05-31 2014-12-04 Immunogen, Inc. Conjugates comprising cell-binding agents and cytotoxic agents
JP6486908B2 (ja) 2013-05-31 2019-03-20 モレキュラー パートナーズ アクチェンゲゼルシャフト 肝細胞増殖因子に結合する設計アンキリン反復タンパク質
JP6644717B2 (ja) * 2014-03-14 2020-02-12 ジェネンテック, インコーポレイテッド 異種ポリペプチドを分泌させるための方法及び組成物
MA39776A (fr) 2014-03-24 2017-02-01 Hoffmann La Roche Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf
LT3189056T (lt) 2014-09-03 2020-09-25 Immunogen, Inc. Citotoksiniai benzodiazepinai
US9381256B2 (en) 2014-09-03 2016-07-05 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
NZ735803A (en) 2015-04-02 2021-12-24 Molecular Partners Ag Designed ankyrin repeat domains with binding specificity for serum albumin
US10220180B2 (en) 2015-10-16 2019-03-05 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
EP3506917A4 (de) 2016-08-31 2020-05-06 President and Fellows of Harvard College Manipulierte bakterienproduzierende therapeutische proteine und verfahren zur verwendung davon
EP3515933B9 (de) 2016-09-22 2023-08-16 Molecular Partners AG Rekombinante bindeproteine und deren verwendung
US10632255B2 (en) 2017-02-15 2020-04-28 Milestone Scientific, Inc. Drug infusion device
KR20240110082A (ko) 2017-02-28 2024-07-12 이뮤노젠 아이엔씨 자기희생적 펩티드 링커 및 이들의 접합체를 갖는 메이탄시노이드 유도체
US20180346488A1 (en) 2017-04-20 2018-12-06 Immunogen, Inc. Cytotoxic benzodiazepine derivatives and conjugates thereof
US11471595B2 (en) 2017-05-04 2022-10-18 Milestone Scientific, Inc. Method and apparatus for performing a peripheral nerve block
TW202413360A (zh) 2017-12-28 2024-04-01 美商伊繆諾金公司 苯二氮平衍生物
TW202102270A (zh) 2019-03-21 2021-01-16 美商伊繆諾金公司 製備細胞結合劑-藥物結合物之方法
MA55520A (fr) 2019-03-29 2022-02-09 Immunogen Inc Dérivés de bis-benzodiazépine cytotoxiques et leurs conjugués avec des agents de liaison à une cellule pour inhiber la croissance cellulaire anormale ou pour traiter des maladies prolifératives
PT3958977T (pt) 2019-04-26 2023-12-15 Immunogen Inc Derivados de camptotecina
US10646660B1 (en) 2019-05-16 2020-05-12 Milestone Scientific, Inc. Device and method for identification of a target region
IL293704A (en) 2019-12-11 2022-08-01 Molecular Partners Ag Designed repeat domains of ankyrin with altered surface residues
KR20230006558A (ko) 2020-05-06 2023-01-10 몰리큘라 파트너스 아게 신규한 안키린 반복 결합 단백질 및 그의 용도
US11834504B2 (en) 2021-03-09 2023-12-05 Molecular Partners Ag DARPin based multi-specific t-cell engagers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078051B1 (de) * 1998-05-13 2007-12-12 Domantis Limited Phagen-display-selektionssystem für korrekt gefaltete proteine

Also Published As

Publication number Publication date
US20150057186A1 (en) 2015-02-26
KR101268939B1 (ko) 2013-05-30
ATE448305T1 (de) 2009-11-15
US9447142B2 (en) 2016-09-20
NZ564695A (en) 2009-02-28
IL188518A0 (en) 2008-04-13
JP2009500027A (ja) 2009-01-08
AU2006268780B2 (en) 2011-03-24
DK1902131T3 (da) 2010-03-01
CA2614512A1 (en) 2007-01-18
RU2412249C2 (ru) 2011-02-20
MX2008000345A (es) 2008-04-02
ES2335136T3 (es) 2010-03-22
CN101213299B (zh) 2013-03-27
CN101213299A (zh) 2008-07-02
NO20080665L (no) 2008-02-05
ZA200710687B (en) 2008-11-26
US20110118146A1 (en) 2011-05-19
US8846577B2 (en) 2014-09-30
BRPI0613593A2 (pt) 2011-01-18
CA2614512C (en) 2014-01-07
IL188518A (en) 2011-04-28
EP1902131A1 (de) 2008-03-26
PL1902131T3 (pl) 2010-05-31
JP5042218B2 (ja) 2012-10-03
WO2007006665A1 (en) 2007-01-18
EP1902131B1 (de) 2009-11-11
RU2008104174A (ru) 2009-08-20
HK1122839A1 (en) 2009-05-29
AU2006268780A1 (en) 2007-01-18
KR20080035603A (ko) 2008-04-23

Similar Documents

Publication Publication Date Title
DE602006010386D1 (en) Phagen-display mittels cotranslationaler translokation von fusionspolypeptiden
JP2009500027A5 (de)
Daugherty Protein engineering with bacterial display
DE60138764D1 (de) Methode zur identifikation und isolation von peptide die andere moleküle binden aus kombinatorische proteinbibliotheken mit einer c-typ lectin-ähnlichen domäne als gerüststruktur
Foster et al. Methods for the creation of cyclic peptide libraries for use in lead discovery
IL156910A0 (en) Isolating cells expressing secreted proteins
Hauser et al. Novel approaches leading towards peptide GPCR de‐orphanisation
EP2284270A3 (de) Verfahren zur Identifizierung und Isolierung von bindenden Polypeptiden aus kombinatorischen Bibliotheken von Proteinen mit der Gerüststruktur von lectinähnlichen Domänen vom C-typ
ZA200800104B (en) Novel Phage Display Technologies
Stern et al. Titratable avidity reduction enhances affinity discrimination in mammalian cellular selections of yeast-displayed ligands
MX2009012326A (es) Peptidos de señalizacion.
Bowen et al. Screening of yeast display libraries of enzymatically treated peptides to discover macrocyclic peptide ligands
Bacon et al. Isolation of chemically cyclized peptide binders using yeast surface display
Bosma et al. Genetically encoded libraries of constrained peptides
Waraho et al. Versatile selection technology for intracellular protein–protein interactions mediated by a unique bacterial hitchhiker transport mechanism
JP2020521460A5 (de)
Tresnak et al. Deep antimicrobial activity and stability analysis inform Lysin sequence–function mapping
US20040176578A1 (en) Fluorescent dye binding peptides
Peña et al. In vitro and in vivo production and split-intein mediated ligation (SIML) of circular bacteriocins
GB201102700D0 (en) Protein secretion
Frisch et al. From EST to IHC: human antibody pipeline for target research
PT2401373E (pt) Apresentação em pix de fago independente de sequência sinal
Veggiani et al. Peptides meet ubiquitin: Simple interactions regulating complex cell signaling
Christ et al. Identification of protein domains by shotgun proteolysis
WO2006089801A3 (de) Verfahren zum redox-potential-abhängigen nachweis von targetmolekülen durch wechselwirkende polypeptide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition